首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
CrizotinibDevelopment of resistance in lung adenocarcinoma: case report
被引:0
|
作者
:
机构
:
来源
:
Reactions Weekly
|
2015年
/ 1539卷
/ 1期
关键词
:
D O I
:
10.1007/s40278-015-7663-z
中图分类号
:
学科分类号
:
摘要
:
引用
收藏
页码:108 / 108
相关论文
共 50 条
[31]
AntineoplasticsDevelopment of resistance in lung adenocarcinoma : case report
[J].
Reactions Weekly,
2022,
1908
(1)
: 64
-
64
[32]
AntineoplasticsDevelopment of resistance in the lung adenocarcinoma: case report
[J].
Reactions Weekly,
2018,
1695
(1)
: 41
-
41
[33]
GefitinibAcquired resistance in Lung adenocarcinoma: case report
[J].
Reactions Weekly,
2018,
1683
(1)
: 328
-
328
[34]
VandetanibDevelopment of resistance in lung adenocarcinoma: case report
[J].
Reactions Weekly,
2018,
1693
(1)
: 495
-
495
[35]
VandetanibDevelopment of resistance in lung adenocarcinoma: case report
[J].
Reactions Weekly,
2018,
1718
(1)
: 207
-
207
[36]
ErlotinibAcquired resistance in lung adenocarcinoma: case report
[J].
Reactions Weekly,
2019,
1763
(1)
: 150
-
150
[37]
IcotinibDevelopment of resistance in lung adenocarcinoma: case report
[J].
Reactions Weekly,
2019,
1737
(1)
: 156
-
156
[38]
VemurafenibAcquired resistance in lung adenocarcinoma: case report
[J].
Reactions Weekly,
2018,
1713
(1)
: 341
-
341
[39]
GefitinibDevelopment of resistance in lung adenocarcinoma: case report
[J].
Reactions Weekly,
2015,
1555
(1)
: 94
-
94
[40]
OsimertinibAcquired resistance in lung adenocarcinoma: case report
[J].
Reactions Weekly,
2019,
1735
(1)
: 205
-
205
←
1
2
3
4
5
→